These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Genetic analyses of the chimeric CYP11B1/CYP11B2 gene in a Korean family with glucocorticoid-remediable aldosteronism. Lee IS; Kim SY; Jang HW; Kim MK; Lee JH; Lee YH; Jo YS J Korean Med Sci; 2010 Sep; 25(9):1379-83. PubMed ID: 20808686 [TBL] [Abstract][Full Text] [Related]
4. Diagnosis of glucocorticoid-remediable aldosteronism in hypertensive children. Kamrath C; Maser-Gluth C; Haag C; Schulze E Horm Res Paediatr; 2011; 76(2):93-8. PubMed ID: 21625068 [TBL] [Abstract][Full Text] [Related]
5. Glucocorticoid-remediable aldosteronism in a large kindred: clinical spectrum and diagnosis using a characteristic biochemical phenotype. Rich GM; Ulick S; Cook S; Wang JZ; Lifton RP; Dluhy RG Ann Intern Med; 1992 May; 116(10):813-20. PubMed ID: 1567095 [TBL] [Abstract][Full Text] [Related]
6. A Chinese pedigree with glucocorticoid remediable aldosteronism. Liu X; Jin L; Zhang H; Ma W; Song L; Zhou X; Cai J Hypertens Res; 2021 Nov; 44(11):1428-1433. PubMed ID: 34462604 [TBL] [Abstract][Full Text] [Related]
7. [Contribution of CYP11B2, REN and AGT genes in genetic predisposition to arterial hypertension associated with hyperaldosteronism]. Chikhladze NM; Samedova KhF; Sudomoina MA; Thant M; Htut ZM; Litonova GN; Favorov AV; Chazova IE; Favorova OO Kardiologiia; 2008; 48(1):37-42. PubMed ID: 18260994 [TBL] [Abstract][Full Text] [Related]
15. New genetic insights in familial hyperaldosteronism. Jackson RV; Lafferty A; Torpy DJ; Stratakis C Ann N Y Acad Sci; 2002 Sep; 970():77-88. PubMed ID: 12381543 [TBL] [Abstract][Full Text] [Related]
16. A new presentation of the chimeric CYP11B1/CYP11B2 gene with low prevalence of primary aldosteronism and atypical gene segregation pattern. Carvajal CA; Campino C; Martinez-Aguayo A; Tichauer JE; Bancalari R; Valdivia C; Trejo P; Aglony M; Baudrand R; Lagos CF; Mellado C; Garcia H; Fardella CE Hypertension; 2012 Jan; 59(1):85-91. PubMed ID: 22083159 [TBL] [Abstract][Full Text] [Related]
17. Aldosterone-producing adenomas do not contain glucocorticoid-remediable aldosteronism chimeric gene duplications. Carroll J; Dluhy R; Fallo F; Pistorello M; Bradwin G; Gomez-Sanchez CE; Mortensen R J Clin Endocrinol Metab; 1996 Dec; 81(12):4310-2. PubMed ID: 8954032 [TBL] [Abstract][Full Text] [Related]
18. Coexistence of different phenotypes in a family with glucocorticoid-remediable aldosteronism. Fallo F; Pilon C; Williams TA; Sonino N; Morra Di Cella S; Veglio F; De Iasio R; Montanari P; Mulatero P J Hum Hypertens; 2004 Jan; 18(1):47-51. PubMed ID: 14688810 [TBL] [Abstract][Full Text] [Related]
19. Clinical and pathological diversity of primary aldosteronism, including a new familial variety. Gordon RD; Stowasser M; Tunny TJ; Klemm SA; Finn WL; Krek AL Clin Exp Pharmacol Physiol; 1991 May; 18(5):283-6. PubMed ID: 2065471 [TBL] [Abstract][Full Text] [Related]
20. Glucocorticoid remediable aldosteronism: low morbidity and mortality in a four-generation italian pedigree. Mulatero P; di Cella SM; Williams TA; Milan A; Mengozzi G; Chiandussi L; Gomez-Sanchez CE; Veglio F J Clin Endocrinol Metab; 2002 Jul; 87(7):3187-91. PubMed ID: 12107222 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]